Administration of Drugs for Pharmacotherapy of Tuberculosis According to GSP Requirements

Authors

DOI:

https://doi.org/10.53933/sspmpm.v4i2.140

Keywords:

administration, tuberculosis, antituberculosis drugs, pharmacotherapy, GSP

Abstract

This research paper outlines the findings from a comprehensive investigation focused on the dispensation and management of antituberculosis medications in pharmaceutical practices. The examination of antituberculosis medications was conducted using various classification systems, including ATC codes, clinical and pharmacological, classification and legal, nomenclature and legal groups. The study provides a detailed analysis of the harmonization process for GxP standards within Ukraine, offering a thorough understanding of the current practices. Additionally, the research looks into the supply chain dynamics of antituberculosis medication distribution. Developed within the study are strategic guidelines for the proper storage of these medications, essential for maintaining their efficacy and safety. A systematic proposal for the spatial organization of storage facilities in the wholesale sector is presented, ensuring compliance with GSP. The study’s goal was to refine the methodologies involved in the storage and management of antituberculosis drugs, with the ultimate aim of enhancing the efficiency of tuberculosis treatment protocols. This, in turn, is expected to elevate the caliber of healthcare delivery and pharmaceutical care available to patients afflicted with tuberculosis. Expanding on the study's contributions, the paper highlights the implications of these findings for public health policy and the potential to streamline pharmaceutical organization. By drawing attention to the criticality of adherence to rigorous storage protocols, the research underscores the necessity of meticulous oversight in the pharmaceutical supply chain. The insights gained from the study are not only pivotal for healthcare providers but also for policymakers tasked with the mandate of curbing the tuberculosis epidemic. The proposed recommendations provide a scaffold for future enhancements in drug management practices.

Author Biography

Alina Osyntseva, Lviv Medical University

PhD in Pharmaceutical Sciences, Lviv Medical University

Public Organization “Association of Medical and Pharmaceutical Law”

References

Shapovalova V., Shapovalov V., Osyntseva A. et al. Organization of the pharmaceutical business, industrial pharmacy and forensic pharmacy concerning the competences of quality management during the circulation of medical products: GxP standards. Actual problems of medicine and pharmacy. 2022. Vol.3. No.2. P.1–20. URL: https://doi.org/10.52914/apmp.v3i2.44 DOI: https://doi.org/10.52914/apmp.v3i2.44

Instruction ST-42-5.0:2014. Good distribution practices. K.: Ministry of Health of Ukraine, 2014. URL: https://www.dls.gov.ua/wp-content/uploads/2019/06/%D0%9D%D0%B0%D0%BB%D0%B5%D0%B6%D0%BD%D0%B0-%D0%BF%D1%80%D0%B0%D0%BA%D1%82%D0%B8%D0%BA%D0%B0-%D0%B4%D0%B8%D1%81%D1%82%D1%80%D0%B8%D0%B1%D1%83%D1%86%D1%96%D1%97.pdf

WHO: mortality from tuberculosis is increasing in Europe, Ukraine is among the "leaders". URL: https://www.radiosvoboda.org/a/news-ukrayina-europa-tuberkulioz-smertnist/32332592.html

Tuberculosis and war: how Ukraine confronts two threats at the same time. URL: https://phc.org.ua/news/tuberkuloz-i-viyna-yak-ukraina-protistoit-dvom-zagrozam-odnochasno

Shapovalov (Jr.) V., Shapovalova V., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol.51. Nо.1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.

Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P.1–24. URL: https://doi.org/10.53933/sspmpm.v2i4.69 DOI: https://doi.org/10.53933/sspmpm.v2i4.69

Vovk D., Puhach O., Bachynska L. et al. The Role of the general practitioner-family doctor in the pharmacotherapy of Tuberculosis during the war. SSP Modern Pharmacy and Medicine. 2023. Vo.3. No.3. P.1-7. URL: https://doi.org/10.53933/sspmpm.v3i3.102 DOI: https://doi.org/10.53933/sspmpm.v3i3.102

Osyntseva A., Shapovalov V. Management and marketing of circulation of first-line antituberculosis medicines: use of innovative research technologies. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.4. P.1-13. URL: https://doi.org/10.53933/sspmpm.v3i4.114 DOI: https://doi.org/10.53933/sspmpm.v3i4.114

Osyntseva A. Tuberculosis: pharmacognosy, medicinal plant raw materials, medicinal plants, phytotherapy. SSP Modern Pharmacy and Medicine. 2024. Vol.4. No.1. P.1-10. P.1-10. URL: https://doi.org/10.53933/sspmpm.v4i1.130 DOI: https://doi.org/10.53933/sspmpm.v4i1.130

Shapovalov V.V., Shapovalova V.O., Vyshar H.M. et al. Pharmaceutical law regarding the stages of creation of normative legal acts that regulate the activity of the pharmaceutical industry in the health care system. Herald of pharmacology and pharmacy. 2004. No. 8. P. 53–55.

Shapovalova V.O., Shapovalov V.V., Vyshar H.M. Development of measures to improve the regional system of adaptive management of the appropriate range of medicinal products. Ukrainian Herald of Psychoneurology. 2006. T. 14. Issue 2 (appendix). P.197–235.

Shapovalova V.O., Vyshar H.M., Shapovalov V.V. Development of the VSHR module for regional provision of the appropriate range of medicines. Creation, production, standardization, pharmacoeconomic research of medicines and biologically active supplements. Kh., 2006. P. 339–340.

Gryzodoub O., Shapovalov V. Quality systems in Pharmacy: multidisciplinary context of the State Pharmacopoeia of Ukraine. SSP Modern Law and Practice. 2023. Vol.3. No.1. P.1-23. URL: https://doi.org/10.53933/sspmlp.v3i1.81 DOI: https://doi.org/10.53933/sspmlp.v3i1.81

Order of the Ministry of Health of Ukraine "On approval of standards of medical care "Tuberculosis". 19.01.2023. No. 102 URL: https://www.dec.gov.ua/wp-content/uploads/2023/01/43242-dn_102_19012023.pdf

Tuberculosis. Evidence-based clinical guidelines. National Health Service of Ukraine. URL: https://www.dec.gov.ua/wp-content/uploads/2021/11/2021_11_18_kn_tuberkuloz.pdf .

Tuberculosis. The clinical guideline is based on evidence. Updated in January 2023. National Health Service of Ukraine. URL: https://www.dec.gov.ua/wp-content/uploads/2023/01/klinichna-nastanova-tuberkuloz-sichen-2023.pdf.

Standards of medical care "Tuberculosis". National Health Service of Ukraine. URL: https://www.dec.gov.ua/wp-content/uploads/2023/01/43243-dn_102_19012023_dod.pdf.

Petrenko V.I., Todoriko L.D., Hryschuk L.A. etc. Physiology: nats. textbook K.: VSV "Medicine", 2015. 472 p.

National Health Service of Ukraine. Official web-site. URL: https://nszu.gov.ua.

National Health Service of Ukraine concerning support and treatment of patients with tuberculosis. National Health Service of Ukraine. URL: https://www.kmu.gov.ua/news/nszu-pro-suprovid-ta-likuvannya-paciyentiv-z-tuberkulozom.

WHO Model Lists of Essential Medicines. World Health Organization. URL: https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists

Shapovalova V. The ICD-11 for the Twenty-First Century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 1. P. 1-13. URL: https://doi.org/10.53933/sspmpm.v2i1.37. DOI: https://doi.org/10.53933/sspmpm.v2i1.37

Shapovalov V. (Jr.), Gudzenko A., Shapovalova V. et al. Concerning the importance of forensic and pharmaceutical researches to improve patients’ accessibility to medicines. Pharmacia. 2017. Vol. 65. No. 2. Р. 23-29. URL: http://bsphs.org/wp-content/uploads/2017/07/Shapovalov.pdf.

ATC-classification. Compendium on-line. URL: http://compendium.com.ua/atc.

Order of the Ministry of Health of Ukraine “On approval of the sixteenth issue of the State formulary of medicines and ensuring its availability”. 12.03.2024. No. 418. URL: https://www.dec.gov.ua/materials/chinnij-vipusk-derzhavnogo-formulyara-likarskih-zasobiv/?role=ua

Shapovalova V., Shapovalov V., Zbrozhek S. et al. Clinical-pharmacological and pharmaceutical characteristics of medicines affecting the nervous system. Kharkiv-Kyiv, 2017. First Publ. 60p.

Shapovalova V., Gudzenko A., Shapovalov V. et al. Clinical-pharmacological and pharmaceutical characteristics of medicines affecting the nervous system. Kharkiv-Kyiv, 2017. Second Publ. 40p.

Order of the Ministry of Health of Ukraine «On the approval of the Lists of poisonous and potent medicinal products». 17.08.2007. No. 490. URL: http://zakon0.rada.gov.ua/laws/show/z1007-07 .

Resolution of the Cabinet of Ministers of Ukraine «On the approval of the Procedure for conducting activities related to the circulation of narcotic drugs, psychotropic substances and precursors, and control over their circulation». 03.06.2009. No.589. URL: http://zakon2.rada.gov.ua/laws/show/589-2009-п .

Order of the Ministry of Health of Ukraine «About some issues of acquisition, transportation, storage, release, use and destruction of narcotic drugs, psychotropic substances and precursors in health care institutions». 07.08.2015. No. 494. URL: https://zakon.rada.gov.ua/laws/show/z1028-15#Text.

Shapovalov V., Komar L., Omelchenko V. Regime of control of medicines of different classification and legal groups. Combined medicines. Kharkiv, 2017. 26p.

Order of the Ministry of Health of Ukraine «On the approval of the Rules for issuing prescriptions and requirements-orders for medicines, the Procedure for issuing medicines from pharmacies and their structural subdivisions, Instructions on the procedure for storing, accounting and destroying prescription forms and requirements-orders». 19.07.2005. No.360. URL: http://zakon2.rada.gov.ua/laws/show/z0782-05 .

Ryshchenko O., Shapovalov V., Shapovalova V., Kapielnikova Ye. Organizational and legal implementation World Health Organization recommendations for pharmaceutical correction of patients with chronic pain syndrome the principles of medical and pharmaceutical law. Ukrainian herald of psychoneurology. 2015. Vol.23. Iss.2(83). P.100–104. URL: https://uvnpn.com.ua/upload/iblock/769/769b5b807ade2a923624a1594b6562e2.pdf

Shapovalova V., Vasina Ju., Shapovalov V. Study of the circulation system of extemporaneous medicinal products in Ukraine on the basis of pharmaceutical law. Pharmaceutical Journal. 2016. No.1. P. 77–85.

Zbrozhek S., Shapovalova V., Shapovalov V. et al. Organizational and legal research of indicators of incidence and prevalence of diabetes mellitus in countryside areas. Annals of Mechnikov Institute. 2017. No.1. P. 44–53. URL: http://www.imiamn.org.ua/journal/1_2017/zmist1_2017.html .

Shapovalov V., Gudzenko A., Shapovalova V. Organizational and legal aspects of the use of pharmacoeconomic analysis of multivitamin complexes for pharmaceutical provision of military personnel. The Pharma Innovation Journal. 2018. Vol.7. Iss.10. P.166–169. URL: http://www.thepharmajournal.com/archives/2018/vol7issue10/PartD/7-7-147-579.pdf

Scientific and practical commentary to the Criminal Code of Ukraine. Kyiv,2024. URL: https://jurkniga.ua/contents/naukovo-praktichniy-komentar-kriminalnogo-kodeksu-ukrayini.pdf

Shapovalova V. System of drugs circulation based on medical and pharmaceutical law. Actual Problems of Medicine and Pharmacy. 2021. Vol.1. N.1-1. URL: System of drugs circulation based on medical and pharmaceutical law | Actual Problems of Medicine and Pharmacy (apmplmi.com) DOI: https://doi.org/10.52914/apmp-2021-1-6

Shapovalova V. Musculoskeletal health systematic review: clinical and pharmacological, organizational and legal, administration and pharmaceutical management aspects. SSP Modern Pharmacy and Medicine. 2024. Vol.4. No.2. P.1-12. URL: https://doi.org/10.53933/sspmpm.v4i2.134 DOI: https://doi.org/10.53933/sspmpm.v4i2.134

Shapovalova V. Post-Traumatic Stress Disorder: administration, clinical and pharmacological, organizational and legal, pharmaceutical management, recent case studies. SSP Modern Pharmacy and Medicine. 2024. Vol.4. No.1. P.1-8. URL: https://doi.org/10.53933/sspmpm.v4i1.123 DOI: https://doi.org/10.53933/sspmpm.v4i1.123

Shapovalova V. Extemporaneous preparations in the pharmacotherapy of nervous system disorders: pharmaceutical management, marketing, analysis, application. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.4. P.1-7. URL: https://doi.org/10.53933/sspmpm.v3i4.111. DOI: https://doi.org/10.53933/sspmpm.v3i4.111

Shapovalova V. Pharmacotherapy of Depressive disorders in conditions of coronavirus disease: pharmacoeconomic experimental study. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.3. P.1-11. URL: https://doi.org/10.53933/sspmpm.v3i3.101 DOI: https://doi.org/10.53933/sspmpm.v3i3.101

Shapovalova V. Interdisciplinary pharmacoeconomic research concerning the pharmacotherapy of Аlcoholic Hepatitis in conditions of COVID-19 pandemic. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.2. P.1-10. URL: https://doi.org/10.53933/sspmpm.v3i2.87 DOI: https://doi.org/10.53933/sspmpm.v3i2.87

Shapovalova V. Alcoholic Hepatitis: An experimental meta-analysis. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.1. P.1-11. DOI: https://doi.org/10.53933/sspmpm.v3i1.77. URL: https://doi.org/10.53933/sspmpm.v3i1.77 DOI: https://doi.org/10.53933/sspmpm.v3i1.77

Shapovalova V. Monkeypox virus – new challenges of modernity: experimental organizational and legal, clinical and pharmacological studies. SSP Modern Pharmacy and Medicine. 2022. Vol.2. N.3. P.1–15. URL: https://doi.org/10.53933/sspmpm.v2i3.54 DOI: https://doi.org/10.53933/sspmpm.v2i3.54

Downloads

Published

2024-04-24

How to Cite

Osyntseva, A. (2024). Administration of Drugs for Pharmacotherapy of Tuberculosis According to GSP Requirements. SSP Modern Pharmacy and Medicine, 4(2), 1–17. https://doi.org/10.53933/sspmpm.v4i2.140

Issue

Section

Health Sciences. Pharmacy